209 related articles for article (PubMed ID: 25667988)
1. Incidence and causes of hospital readmission in pediatric patients after hematopoietic cell transplantation.
Shulman DS; London WB; Guo D; Duncan CN; Lehmann LE
Biol Blood Marrow Transplant; 2015 May; 21(5):913-9. PubMed ID: 25667988
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).
Bejanyan N; Bolwell BJ; Lazaryan A; Rybicki L; Tench S; Duong H; Andresen S; Sobecks R; Dean R; Pohlman B; Kalaycio M; Copelan EA
Biol Blood Marrow Transplant; 2012 Jun; 18(6):874-80. PubMed ID: 22040844
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience.
Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK
Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457
[TBL] [Abstract][Full Text] [Related]
4. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals.
Dhakal B; Giri S; Levin A; Rein L; Fenske TS; Chhabra S; Shah NN; Szabo A; D'Souza A; Pasquini M; Hari P; Hamadani M
JAMA Netw Open; 2019 Jul; 2(7):e196476. PubMed ID: 31276175
[TBL] [Abstract][Full Text] [Related]
6. Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall Survival.
Crombie J; Spring L; Li S; Soiffer RJ; Antin JH; Alyea EP; Glotzbecker B
Biol Blood Marrow Transplant; 2017 Jan; 23(1):113-118. PubMed ID: 27789360
[TBL] [Abstract][Full Text] [Related]
7. Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience.
Verdeguer A; de Heredia CD; González M; Martínez AM; Fernández-Navarro JM; Pérez-Hurtado JM; Badell I; Gómez P; González ME; Muñoz A; Díaz MA;
Bone Marrow Transplant; 2011 Jan; 46(1):119-24. PubMed ID: 20228849
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell Transplantation.
Hill JA; Moon SH; Chandak A; Zhang Z; Boeckh M; Maziarz RT
Transplant Cell Ther; 2022 Sep; 28(9):619.e1-619.e8. PubMed ID: 35764288
[TBL] [Abstract][Full Text] [Related]
9. Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation.
Fang J; Su Y; Zavras PD; Raval AD; Tang Y; Perales MA; Giralt S; Stern A; Papanicolaou GA
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1937-1947. PubMed ID: 32640313
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study.
Czyżewski K; Styczyński J; Giebel S; Frączkiewicz J; Salamonowicz M; Zając-Spychala O; Zaucha-Prażmo A; Drozd-Sokołowska J; Waszczuk-Gajda A; Dybko J; Mańko J; Zalas-Więcek P; Gałązka P; Wysocki M; Kowalczyk J; Wachowiak J; Goździk J; Basak GW; Kałwak K; Adamska M; Hus M; Piekarska A; Sadowska-Klasa A; Mensah-Glanowska P; Kyrcz-Krzemień S; Biernat M; Wierzbowska A; Rzepecki P; Tomaszewska A; Hałaburda K; Gil L;
Ann Hematol; 2019 Sep; 98(9):2197-2211. PubMed ID: 31321454
[TBL] [Abstract][Full Text] [Related]
11. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
12. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
Du J; Liu J; Gu J; Zhu P
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
[TBL] [Abstract][Full Text] [Related]
14. Hospital readmission following transplantation: identifying risk factors and designing preventive measures.
McKenna DR; Sullivan MR; Hill JM; Lowrey CH; Brown JR; Hickman J; Meehan KR
J Community Support Oncol; 2015 Sep; 13(9):316-22. PubMed ID: 26859751
[TBL] [Abstract][Full Text] [Related]
15. Pericardial effusion after pediatric hematopoietic cell transplant.
Aldoss O; Gruenstein DH; Bass JL; Steinberger J; Zhang Y; Defor TE; Tolar J; Verneris MR; Orchard PJ
Pediatr Transplant; 2013 May; 17(3):294-9. PubMed ID: 23464863
[TBL] [Abstract][Full Text] [Related]
16. Predictors and impacts of hospital readmissions following liver transplantation.
Yataco M; Cowell A; David W; Keaveny AP; Taner CB; Patel T
Ann Hepatol; 2016; 15(3):356-62. PubMed ID: 27049489
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation.
Peffault De Latour R; Chevallier P; Blaise D; Alami S; Lévy-Bachelot L; Allavoine T; Tadmouri A; Blomkvist J; Duhamel A; Srour M; Beauvais D; Yakoub-Agha I
J Med Virol; 2020 Dec; 92(12):3665-3673. PubMed ID: 32297984
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis.
Akhter SA; Badami A; Murray M; Kohmoto T; Lozonschi L; Osaki S; Lushaj EB
Ann Thorac Surg; 2015 Sep; 100(3):884-9. PubMed ID: 26095106
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review.
Sousa H; Boutolleau D; Ribeiro J; Teixeira AL; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1958-67. PubMed ID: 25139217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
